- Home
- UTHR vs RIVN Comparison
UTHR vs RIVN Comparison
Compare UTHR & RIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- RIVN
- Stock Information
- Founded
- UTHR 1996
- RIVN 2009
- Country
- UTHR United States
- RIVN United States
- Employees
- UTHR N/A
- RIVN N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- RIVN Auto Manufacturing
- Sector
- UTHR Health Care
- RIVN Consumer Discretionary
- Exchange
- UTHR Nasdaq
- RIVN Nasdaq
- Market Cap
- UTHR 15.5B
- RIVN 13.3B
- IPO Year
- UTHR 1999
- RIVN 2021
- Fundamental
- Price
- UTHR $364.00
- RIVN $10.05
- Analyst Decision
- UTHR Buy
- RIVN Buy
- Analyst Count
- UTHR 14
- RIVN 23
- Target Price
- UTHR $370.86
- RIVN $15.67
- AVG Volume (30 Days)
- UTHR 371.2K
- RIVN 43.1M
- Earning Date
- UTHR 10-30-2024
- RIVN 11-07-2024
- Dividend Yield
- UTHR N/A
- RIVN N/A
- EPS Growth
- UTHR 25.10
- RIVN N/A
- EPS
- UTHR 22.72
- RIVN N/A
- Revenue
- UTHR $2,756,200,000.00
- RIVN $4,551,000,000.00
- Revenue This Year
- UTHR $26.32
- RIVN $7.44
- Revenue Next Year
- UTHR $10.37
- RIVN $18.95
- P/E Ratio
- UTHR $16.00
- RIVN N/A
- Revenue Growth
- UTHR 25.04
- RIVN 20.33
- 52 Week Low
- UTHR $208.62
- RIVN $8.26
- 52 Week High
- UTHR $417.82
- RIVN $24.62
- Technical
- Relative Strength Index (RSI)
- UTHR 44.48
- RIVN 45.29
- Support Level
- UTHR $353.65
- RIVN $9.55
- Resistance Level
- UTHR $417.82
- RIVN $10.72
- Average True Range (ATR)
- UTHR 11.21
- RIVN 0.73
- MACD
- UTHR -4.22
- RIVN 0.00
- Stochastic Oscillator
- UTHR 16.64
- RIVN 15.28
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About RIVN Rivian Automotive Inc.
Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).